Molecular basis for selective serotonin reuptake inhibition by the antidepressant agent fluoxetine (Prozac).
about
Monoamine transporters: insights from molecular dynamics simulationsInsights to ligand binding to the monoamine transporters-from homology modeling to LeuBAT and dDATDesigning modulators of monoamine transporters using virtual screening techniquesExploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics StudyChronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift.Development of potent dopamine-norepinephrine uptake inhibitors (DNRIs) based on a (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol molecular template.Properties of an inward-facing state of LeuT: conformational stability and substrate release.Mechanism of Paroxetine (Paxil) Inhibition of the Serotonin Transporter.Genetically encoded photocrosslinkers locate the high-affinity binding site of antidepressant drugs in the human serotonin transporter.Structure-activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the 5-HT transporterBinding site residues control inhibitor selectivity in the human norepinephrine transporter but not in the human dopamine transporterImportance of the Extracellular Loop 4 in the Human Serotonin Transporter for Inhibitor Binding and Substrate Translocation.Non-classical mechanism of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor channel block by fluoxetine.Analgesic Mechanisms of Antidepressants for Neuropathic Pain.Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: an insight from molecular dynamics simulation study.Structural basis for recognition of diverse antidepressants by the human serotonin transporter.The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome.
P2860
Q26777242-FA2AFF39-F96A-4FD0-89D9-FD01F067B060Q26781554-25828FE4-B4C5-44F1-8161-7AE499C13F9FQ26781605-6553C238-6576-49AA-8C76-61AB60AB064FQ28833274-8AB5DE07-03A5-4765-AB8F-64F2D4B8241DQ30906677-3E3E0338-3F62-430B-8808-EB130DA18BB0Q35054544-C1B9E8A2-F556-4ED5-A397-9CC8A1FDFD45Q35222032-C31DB5D3-057D-49BD-9ED7-E1ADBF3CD25CQ36754967-05069E76-45A6-4425-8A16-4CC6ED8488F7Q36819600-D24457CB-BB64-4421-B7A6-8F560D49E311Q38572969-C3CA699D-9CA1-478E-9AD1-B513D368C4BEQ40390385-9DBACB92-42B1-443E-ABD3-EB5B86C10BA6Q41027994-42DF8CD2-8735-4899-B910-6902DAFCA15AQ41626850-63BE1AF8-C1D9-486C-9031-B3F9BAF82D23Q47099589-CC2EF58C-D749-4E34-B306-EFF55937D092Q48066819-DB72ED9E-FC30-4E1E-9A59-CA5656926808Q49594975-288EB3A1-3223-49F3-8A20-235FCB61D9CBQ54988096-A3D263CD-2B72-475F-AA62-9233B7FD63D5
P2860
Molecular basis for selective serotonin reuptake inhibition by the antidepressant agent fluoxetine (Prozac).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Molecular basis for selective ...... ant agent fluoxetine (Prozac).
@en
Molecular basis for selective ...... ntidepressant agent fluoxetine
@nl
type
label
Molecular basis for selective ...... ant agent fluoxetine (Prozac).
@en
Molecular basis for selective ...... ntidepressant agent fluoxetine
@nl
prefLabel
Molecular basis for selective ...... ant agent fluoxetine (Prozac).
@en
Molecular basis for selective ...... ntidepressant agent fluoxetine
@nl
P2093
P50
P356
P1476
Molecular basis for selective ...... ant agent fluoxetine (Prozac).
@en
P2093
Heidi Koldsø
Linda Grønborg Zachariassen
Nicolai Stuhr-Hansen
P304
P356
10.1124/MOL.113.091249
P577
2014-02-10T00:00:00Z